[HTML][HTML] Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options

JCO Sardi, L Scorzoni, T Bernardi… - Journal of medical …, 2013 - microbiologyresearch.org
The incidence of fungal infections has increased significantly, so contributing to morbidity
and mortality. This is caused by an increase in antimicrobial resistance and the restricted …

[HTML][HTML] Recent insights into Candida albicans biofilm resistance mechanisms

L Mathé, P Van Dijck - Current genetics, 2013 - Springer
Like other microorganisms, free-living Candida albicans is mainly present in a three-
dimensional multicellular structure, which is called a biofilm, rather than in a planktonic form …

Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond

R Yin, T Dai, P Avci, AES Jorge, WCMA De Melo… - Current opinion in …, 2013 - Elsevier
Highlights•Light-based anti-infectives work against biofilms and localized
infections.•Ultraviolet C light will kill all pathogens without killing host mammalian …

Adhesins in human fungal pathogens: glue with plenty of stick

PWJ de Groot, O Bader, AD de Boer, M Weig… - Eukaryotic …, 2013 - Am Soc Microbiol
Understanding the pathogenesis of an infectious disease is critical for developing new
methods to prevent infection and diagnose or cure disease. Adherence of microorganisms to …

Self‐defensive biomaterial coating against bacteria and yeasts: polysaccharide multilayer film with embedded antimicrobial peptide

G Cado, R Aslam, L Séon, T Garnier… - Advanced Functional …, 2013 - Wiley Online Library
Prevention of pathogen colonization of medical implants is a major medical and financial
issue since infection by microorganisms constitutes one of the most serious complications …

Antifungal therapy with an emphasis on biofilms

CG Pierce, A Srinivasan, P Uppuluri… - Current opinion in …, 2013 - Elsevier
Highlights•Fungal infections affect an expanding population of immunosuppressed
patients.•The current arsenal of antifungal drugs is exceedingly limited.•Toxicity problems …

Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs

CG Pierce, JL Lopez-Ribot - Expert opinion on drug discovery, 2013 - Taylor & Francis
Introduction: Targeting pathogenetic mechanisms, rather than essential processes,
represents a very attractive alternative for the development of new antibiotics. This may be …

High-throughput screening of a collection of known pharmacologically active small compounds for identification of Candida albicans biofilm inhibitors

SA Siles, A Srinivasan, CG Pierce… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Candida albicans is the most common etiologic agent of systemic fungal infections with
unacceptably high mortality rates. The existing arsenal of antifungal drugs is very limited and …

Molecular identification, antifungal susceptibility profile, and biofilm formation of clinical and environmental Rhodotorula species isolates

JM Nunes, FC Bizerra, RC Ferreira… - Antimicrobial agents …, 2013 - Am Soc Microbiol
Rhodotorula species are emergent fungal pathogens capable of causing invasive infections,
primarily fungemia. They are particularly problematic in immunosuppressed patients when …

[HTML][HTML] Human Serum Promotes Candida albicans Biofilm Growth and Virulence Gene Expression on Silicone Biomaterial

YH Samaranayake, BPK Cheung, JYY Yau… - PLoS …, 2013 - journals.plos.org
Objectives Systemic candidal infections are a common problem in hospitalized patients due
to central venous catheters fabricated using silicone biomaterial (SB). We therefore …